<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52-viruses-11-01096">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vuylsteke</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Reyniers</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Lucet</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Nostlinger</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Deblonde</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Libois</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sauvage</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Deprez</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Goffard</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Allard</surname>
    <given-names>S.D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: Results from surveillance reports</article-title>
  <source>Sex. Health</source>
  <year>2019</year>
  <volume>16</volume>
  <fpage>80</fpage>
  <lpage>83</lpage>
  <pub-id pub-id-type="doi">10.1071/SH18071</pub-id>
  <pub-id pub-id-type="pmid">30497542</pub-id>
 </element-citation>
</ref>
